Skip to content
AdminJun 16, 2021< 1 min read

Experiences Implementing Data Synthesis in a Global Life Sciences Company

2021-06-16-Experiences-Implementing-1

Stephen Bamford, Head of Clinical Data Standards & Transparency; IDAR, Global Development, Janssen

A webinar from Stephen Bamford at Janssen describing their experiences with the implementation of synthetic data generation and where it fits in among other PETs.

 

 

Following the acquisition of Replica Analytics by Aetion, the generative AI technology previously known as Replica Synthesis is now Aetion® Generate and continues to create privacy-enhancing synthetic data.
Learn More

RELATED ARTICLES

AdminMay 6, 20241 min read

Navigating the European Union's Medical Device Regulation (MDR)

On May 26, 2021 the European Union’s (EU) Medical Device Regulation (MDR) became effective. The MDR overhauls how the EU ...
Start Reading
Xi FangApr 20, 20241 min read

How to unleash the replicability potential of synthetic data

In today's data-driven world, the need for innovative solutions to evolve alongside the ever-challenging landscape of privacy ...
Start Reading
AdminApr 19, 2024< 1 min read

Case Study: Enhancing clinical trial data sharing with synthetic datasets

Unlock the future of research with our groundbreaking approach to privacy-preserving data sharing. Our case study, "Enhancing ...
Start Reading